INVIVO THERAPEUTICS HOLDINGS CORP. Increase Decrease In Operating Lease Liability
INVIVO THERAPEUTICS HOLDINGS CORP. reported Increase Decrease In Operating Lease Liability of -$260.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2023-11-08
- INVIVO THERAPEUTICS HOLDINGS CORP. increase decrease in operating lease liability for the quarter ending 2023-09-30 was -$66.00K.
- INVIVO THERAPEUTICS HOLDINGS CORP. increase decrease in operating lease liability for the quarter ending 2023-06-30 was -$98.00K.
- INVIVO THERAPEUTICS HOLDINGS CORP. increase decrease in operating lease liability for the quarter ending 2023-03-31 was -$96.00K.
- INVIVO THERAPEUTICS HOLDINGS CORP. increase decrease in operating lease liability for the quarter ending 2022-12-31 was -$93.00K.
- INVIVO THERAPEUTICS HOLDINGS CORP. increase decrease in operating lease liability for fiscal 2022 was -$360.00K.
- INVIVO THERAPEUTICS HOLDINGS CORP. increase decrease in operating lease liability for fiscal 2021 was -$339.00K.
- INVIVO THERAPEUTICS HOLDINGS CORP. increase decrease in operating lease liability for fiscal 2020 was -$294.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$164.00K derived: sum of 2 quarters · filed 2023-11-08 | -$260.00K 10-Q · filed 2023-11-08 | -$353.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | -$98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$194.00K 10-Q · filed 2023-08-09 | -$287.00K derived: sum of 3 quarters · filed 2023-08-09 | -$377.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-03-31 | -$96.00K 10-Q · filed 2023-05-12 | -$189.00K derived: sum of 2 quarters · filed 2023-05-12 | -$279.00K derived: sum of 3 quarters · filed 2023-11-08 | -$369.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$183.00K derived: sum of 2 quarters · filed 2023-11-08 | -$273.00K derived: sum of 3 quarters · filed 2023-11-08 | -$360.00K 10-K · filed 2023-03-01 |
| 2022-09-30 | -$90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$180.00K derived: sum of 2 quarters · filed 2023-11-08 | -$267.00K 10-Q · filed 2023-11-08 | -$357.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$177.00K 10-Q · filed 2023-08-09 | -$267.00K derived: sum of 3 quarters · filed 2023-08-09 | -$359.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$87.00K 10-Q · filed 2023-05-12 | -$177.00K derived: sum of 2 quarters · filed 2023-05-12 | -$269.00K derived: sum of 3 quarters · filed 2023-05-12 | -$347.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$182.00K derived: sum of 2 quarters · filed 2023-03-01 | -$260.00K derived: sum of 3 quarters · filed 2023-03-01 | -$339.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | -$92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$170.00K derived: sum of 2 quarters · filed 2022-11-07 | -$249.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$157.00K 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$79.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$294.00K 10-K · filed 2022-03-07 |